NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Price & Overview
FRA:NZM2 • DK0060336014
Current stock price
The current stock price of NZM2.DE is 51.18 EUR. Today NZM2.DE is up by 0.63%. In the past month the price decreased by -1.27%.
NZM2.DE Key Statistics
- Market Cap
- 21.217B
- P/E
- 27.22
- Fwd P/E
- 25.09
- EPS (TTM)
- 1.88
- Dividend Yield
- 1.71%
NZM2.DE Stock Performance
NZM2.DE Stock Chart
NZM2.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to NZM2.DE.
NZM2.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NZM2.DE. Both the profitability and the financial health of NZM2.DE get a neutral evaluation. Nothing too spectacular is happening here.
NZM2.DE Earnings
On February 25, 2026 NZM2.DE reported an EPS of 0.45 and a revenue of 996.60M. The company missed EPS expectations (-16.62% surprise) and missed revenue expectations (-3.15% surprise).
NZM2.DE Forecast & Estimates
24 analysts have analysed NZM2.DE and the average price target is 63.75 EUR. This implies a price increase of 24.57% is expected in the next year compared to the current price of 51.18.
For the next year, analysts expect an EPS growth of 8.49% and a revenue growth 7.05% for NZM2.DE
NZM2.DE Groups
Sector & Classification
NZM2.DE Financial Highlights
Over the last trailing twelve months NZM2.DE reported a non-GAAP Earnings per Share(EPS) of 1.88. The EPS increased by 87.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.04% | ||
| ROA | 3.57% | ||
| ROE | 5.38% | ||
| Debt/Equity | 0.12 |
NZM2.DE Ownership
NZM2.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SY1 | SYMRISE AG | 17.76 | 10.385B | ||
| 1SYM | SYMRISE AG | 17.74 | 10.15B | ||
| AKZA | AKZO NOBEL N.V. | 11.42 | 8.392B | ||
| AKU1 | AKZO NOBEL N.V. | 11.62 | 8.378B | ||
| EVK | EVONIK INDUSTRIES AG | 14.58 | 7.722B | ||
| SYENS | SYENSQO SA | 10.06 | 4.94B | ||
| AKE | ARKEMA | 11.71 | 4.419B | ||
| WCH | WACKER CHEMIE AG | 186.72 | 4.279B | ||
| UMI | UMICORE | 11.82 | 4.029B | ||
| NVJP | UMICORE | 11.68 | 4.011B | ||
| ACT | ALZCHEM GROUP AG | 27.73 | 1.865B | ||
| RBT | ROBERTET SA | 16.12 | 1.769B | ||
| CRBN | CORBION NV | 12.15 | 1.09B |
Related stock screener links
View all stocks in the Specialty Chemicals Industry | View all stocks in the Materials Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About NZM2.DE
Company Profile
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
Company Info
IPO: 1905-05-27
NOVONESIS (NOVOZYMES) B
Krogshoejvej 36
Bagsvaerd DK
Employees: 11641
NOVONESIS (NOVOZYMES) B / NZM2.DE FAQ
What does NOVONESIS (NOVOZYMES) B do?
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
What is the current price of NZM2 stock?
The current stock price of NZM2.DE is 51.18 EUR. The price increased by 0.63% in the last trading session.
Does NOVONESIS (NOVOZYMES) B pay dividends?
NOVONESIS (NOVOZYMES) B (NZM2.DE) has a dividend yield of 1.71%. The yearly dividend amount is currently 0.86.
How is the ChartMill rating for NOVONESIS (NOVOZYMES) B?
NZM2.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the sector and industry classification for NOVONESIS (NOVOZYMES) B?
NOVONESIS (NOVOZYMES) B (NZM2.DE) operates in the Materials sector and the Chemicals industry.
How is the valuation of NOVONESIS (NOVOZYMES) B (NZM2.DE) based on its PE ratio?
The PE ratio for NOVONESIS (NOVOZYMES) B (NZM2.DE) is 27.22. This is based on the reported non-GAAP earnings per share of 1.88 and the current share price of 51.18 EUR.
Can you provide the market cap for NOVONESIS (NOVOZYMES) B?
NOVONESIS (NOVOZYMES) B (NZM2.DE) has a market capitalization of 21.22B EUR. This makes NZM2.DE a Large Cap stock.